The Constrained Disorder Principle: Beyond Biological Allostasis
Simple Summary
Abstract
1. Introduction
1.1. The Constrained Disorder Principle
1.2. Allostasis
1.3. For the Allostatic Load Model, Is There Pre-Planning?
1.4. Energy Usage: Are We Wasting or Saving Energy to Keep It Balanced?
1.5. Disease: An Allostatic Overload or Getting Out of the Boundaries?
1.6. Predicting Adverse Health Outcomes and Mortality Risk
1.7. Coping with Changes
1.8. Intra and Inter-Individual Variation: Plasticity
1.9. The Benefits of Adding Biological Noise to Improve Health Outcomes
1.10. How Homeostasis, Allostasis, and the CDP Define and Treat Hypertension
2. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
CDP | Constrained disorder principle |
HPA | Hypothalamic–pituitary–adrenal |
AL | Allostatic load |
DHEA | Dehydroepiandrosterone |
ELHS | Emergency life history stage |
HRV | Heart rate variability |
Ee | Minimum energy level required to maintain homeostasis |
Ei | Energy needed to make predictable changes under ideal conditions to adjust to environmental changes |
Eo | Energy cost for unpredictable perturbation |
Eg | Energy in the environment |
Ecr | Endogenous energy |
PRP | Perturbation resistance potential |
SAM | Sympatheticadrenalmedullary |
DNA | Deoxyribonucleic acid |
AI | Artificial intelligence |
References
- Pancaldi, V. Biological noise to get a sense of direction: An analogy between chemotaxis and stress response. Front. Genet. 2014, 5. [Google Scholar] [CrossRef]
- Tsimring, L.S. Noise in biology. Rep. Prog. Phys. 2014, 77, 026601. [Google Scholar] [CrossRef] [PubMed]
- Ilan, Y. The constrained disorder principle defines living organisms and provides a method for correcting disturbed biological systems. Comput. Struct. Biotechnol. J. 2022, 20, 6087–6096. [Google Scholar] [CrossRef]
- Ilan, Y. Making use of noise in biological systems. Prog. Biophys. Mol. Biol. 2023, 178, 83–90. [Google Scholar] [CrossRef]
- Ilan, Y. Constrained disorder principle-based variability is fundamental for biological processes: Beyond biological relativity and physiological regulatory networks. Prog. Biophys. Mol. Biol. 2023, 180–181, 37–48. [Google Scholar] [CrossRef] [PubMed]
- McEwen, B.S.; Wingfield, J.C. The concept of allostasis in biology and biomedicine. Horm. Behav. 2003, 43, 2–15. [Google Scholar] [CrossRef]
- Word, K.R.; Austin, S.H.; Wingfield, J.C. Allostasis revisited: A perception, variation, and risk framework. Front. Ecol. Evol. 2022, 10, 954708. [Google Scholar] [CrossRef]
- Teuscher, C. Revisiting the edge of chaos: Again? Biosystems 2022, 218, 104693. [Google Scholar] [CrossRef]
- Sterling, P.; Eyer, J. Allostasis: A new paradigm to explain arousal pathology. In Handbook of Life Stress, Cognition and Health; John Wiley & Sons: Oxford, UK, 1988; pp. 629–649. [Google Scholar]
- Sterling, P. Principles of Allostasis: Optimal Design, Predictive Regulation, Pathophysiology, and Rational Therapeutics. In Allostasis, Homeostasis, and the Costs of Physiological Adaptation; Cambridge University Press: New York, NY, USA, 2004; pp. 17–64. [Google Scholar]
- Sterling, P. What Is Health? Allostasis and the Evolution of Human Design; MIT Press: Cambridge, MA, USA, 2020. [Google Scholar]
- McEwen, B.S. Protection and damage from acute and chronic stress: Allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N. Y. Acad. Sci. 2004, 1032, 1–7. [Google Scholar] [CrossRef]
- Moingeon, P.; Chenel, M.; Rousseau, C.; Voisin, E.; Guedj, M. Virtual patients, digital twins and causal disease models: Paving the ground for in silico clinical trials. Drug Discov. Today 2023, 28, 103605. [Google Scholar] [CrossRef]
- Bauman, D.E. Regulation of nutrient partitioning during lactation: Homeostasis and homeorhesis revisited. In Ruminant Physiology: Digestion, Metabolism, Growth and Reproduction; CABI Publishing: Wallingford, UK, 2000; pp. 311–328. [Google Scholar]
- Kuenzel, W.J.; Beck, M.M.; Teruyama, R. Neural sites and pathways regulating food intake in birds: A comparative analysis to mammalian systems. J. Exp. Zool. 1999, 283, 348–364. [Google Scholar] [CrossRef]
- Nanni, U.; Ferroni, P.; Riondino, S.; Spila, A.; Valente, M.G.; Del Monte, G.; Roselli, M.; Guadagni, F. Biospecimen Digital Twins: Moving from a “High Quality” to a “Fit-for-Purpose” Concept in the Era of Omics Sciences. Cancer Genom. Proteom. 2023, 20, 211–221. [Google Scholar] [CrossRef]
- Ramsay, D.S.; Woods, S.C. Clarifying the roles of homeostasis and allostasis in physiological regulation. Psychol. Rev. 2014, 121, 225–247. [Google Scholar] [CrossRef]
- De Ridder, D.; Manning, P.; Leong, S.L.; Ross, S.; Vanneste, S. Allostasis in health and food addiction. Sci. Rep. 2016, 6, 37126. [Google Scholar] [CrossRef]
- Juster, R.P.; McEwen, B.S.; Lupien, S.J. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci. Biobehav. Rev. 2010, 35, 2–16. [Google Scholar] [CrossRef] [PubMed]
- Sapolsky, R.M.; Romero, L.M.; Munck, A.U. How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions. Endocr. Rev. 2000, 21, 55–89. [Google Scholar] [CrossRef]
- McEwen, B.S. Protective and Damaging Effects of Stress Mediators. N. Engl. J. Med. 1998, 338, 171–179. [Google Scholar] [CrossRef] [PubMed]
- McEwen, B.S. Protective and damaging effects of stress mediators: Central role of the brain. Dialogues Clin. Neurosci. 2006, 8, 367–381. [Google Scholar] [CrossRef]
- McEwen, B.S. Interacting mediators of allostasis and allostatic load: Towards an understanding of resilience in aging. Metabolism 2003, 52, 10–16. [Google Scholar] [CrossRef]
- Juster, R.-P.; Russell, J.J.; Almeida, D.; Picard, M. Allostatic load and comorbidities: A mitochondrial, epigenetic, and evolutionary perspective. Dev. Psychopathol. 2016, 28, 1117–1146. [Google Scholar] [CrossRef]
- McEwen, B.S. Allostasis and Allostatic Load: Implications for Neuropsychopharmacology. Neuropsychopharmacology 2000, 22, 108–124. [Google Scholar] [CrossRef] [PubMed]
- McEwen, B.S.; Seeman, T. Protective and Damaging Effects of Mediators of Stress: Elaborating and Testing the Concepts of Allostasis and Allostatic Load. Ann. N. Y. Acad. Sci. 1999, 896, 30–47. [Google Scholar] [CrossRef]
- Picard, M.; Juster, R.P.; McEwen, B.S. Mitochondrial allostatic load puts the ‘gluc’ back in glucocorticoids. Nat. Rev. Endocrinol. 2014, 10, 303–310. [Google Scholar] [CrossRef] [PubMed]
- Romero, L.; Dickens, M.; Cyr, N. The Reactive Scope Model—A new model integrating homeostasis, allostasis, and stress. Horm. Behav. 2009, 55, 375–389. [Google Scholar] [CrossRef] [PubMed]
- McEwen, B.S.; Rasgon, N.L. 14—The Brain and Body on Stress: Allostatic Load and Mechanisms for Depression and Dementia. In Depression as a Systemic Illness; Strain, J.J., Blumenfield, M., Eds.; Oxford University Press: Oxford, UK, 2018. [Google Scholar]
- Monaghan, P.; Spencer, K.A. Stress and life history. Curr. Biol. 2014, 24, R408–R412. [Google Scholar] [CrossRef]
- Pahuja, H.K.; Narayan, E.J. Reactive scope model and emergency life history stage provide useful tools for evaluating the stress responses of native Australian lizards living in disturbed landscapes. Conserv. Physiol. 2021, 9, coab097. [Google Scholar] [CrossRef]
- Taff, C. Simulating physiological flexibility in the acute glucocorticoid response to stressors reveals limitations of current empirical approaches. PeerJ 2022, 10, e14039. [Google Scholar] [CrossRef]
- Herman, J.P.; McKlveen, J.M.; Ghosal, S.; Kopp, B.; Wulsin, A.; Makinson, R.; Scheimann, J.; Myers, B. Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response. Compr. Physiol. 2016, 6, 603–621. [Google Scholar] [CrossRef]
- Ilan, Y. Overcoming randomness does not rule out the importance of inherent randomness for functionality. J. Biosci. 2019, 44, 132. [Google Scholar] [CrossRef]
- Ilan, Y. Generating randomness: Making the most out of disordering a false order into a real one. J. Transl. Med. 2019, 17, 49. [Google Scholar] [CrossRef]
- Ilan, Y. Advanced Tailored Randomness: A Novel Approach for Improving the Efficacy of Biological Systems. J. Comput. Biol. 2020, 27, 20–29. [Google Scholar] [CrossRef] [PubMed]
- Ilan, Y. Order Through Disorder: The Characteristic Variability of Systems. Front. Cell Dev. Biol. 2020, 8, 186. [Google Scholar] [CrossRef]
- El-Haj, M.; Kanovitch, D.; Ilan, Y. Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: A novel platform for designing personalized immunotherapies. Immunol. Res. 2019, 67, 337–347. [Google Scholar] [CrossRef]
- Ilan, Y. Randomness in microtubule dynamics: An error that requires correction or an inherent plasticity required for normal cellular function? Cell Biol. Int. 2019, 43, 739–748. [Google Scholar] [CrossRef] [PubMed]
- Ilan, Y. Microtubules: From understanding their dynamics to using them as potential therapeutic targets. J. Cell. Physiol. 2019, 234, 7923–7937. [Google Scholar] [CrossRef]
- Ilan-Ber, T.; Ilan, Y. The role of microtubules in the immune system and as potential targets for gut-based immunotherapy. Mol. Immunol. 2019, 111, 73–82. [Google Scholar] [CrossRef]
- Forkosh, E.; Kenig, A.; Ilan, Y. Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy. Pharmacol. Res. Perspect. 2020, 8, e00616. [Google Scholar] [CrossRef]
- Ilan, Y. Beta-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems. Front. Immunol. 2019, 10, 1143. [Google Scholar] [CrossRef]
- Ilan, Y. Microtubules as a potential platform for energy transfer in biological systems: A target for implementing individualized, dynamic variability patterns to improve organ function. Mol. Cell. Biochem. 2022, 478, 375–392. [Google Scholar] [CrossRef]
- Ilan, Y. Enhancing the plasticity, proper function and efficient use of energy of the Sun, genes and microtubules using variability. Clin. Transl. Discov. 2022, 2, e103. [Google Scholar] [CrossRef]
- Shabat, Y.; Lichtenstein, Y.; Ilan, Y. Short-Term Cohousing of Sick with Healthy or Treated Mice Alleviates the Inflammatory Response and Liver Damage. Inflammation 2021, 44, 518–525. [Google Scholar] [CrossRef] [PubMed]
- Finn, E.H.; Misteli, T. Molecular basis and biological function of variability in spatial genome organization. Science 2019, 365, eaaw9498. [Google Scholar] [CrossRef]
- Chiera, M.; Cerritelli, F.; Casini, A.; Barsotti, N.; Boschiero, D.; Cavigioli, F.; Corti, C.G.; Manzotti, A. Heart Rate Variability in the Perinatal Period: A Critical and Conceptual Review. Front. Neurosci. 2020, 14, 561186. [Google Scholar] [CrossRef]
- Forte, G.; Favieri, F.; Casagrande, M. Heart Rate Variability and Cognitive Function: A Systematic Review. Front. Neurosci. 2019, 13, 710. [Google Scholar] [CrossRef] [PubMed]
- Mitchison, T.; Kirschner, M. Dynamic instability of microtubule growth. Nature 1984, 312, 237–242. [Google Scholar] [CrossRef] [PubMed]
- Kirschner, M.W.; Mitchison, T. Microtubule dynamics. Nature 1986, 324, 621. [Google Scholar] [CrossRef]
- Schutte, A.E.; Kollias, A.; Stergiou, G.S. Blood pressure and its variability: Classic and novel measurement techniques. Nat. Rev. Cardiol. 2022, 19, 643–654. [Google Scholar] [CrossRef]
- Van den Bosch, O.F.C.; Alvarez-Jimenez, R.; de Grooth, H.J.; Girbes, A.R.J.; Loer, S.A. Breathing variability-implications for anaesthesiology and intensive care. Crit. Care 2021, 25, 280. [Google Scholar] [CrossRef]
- Boripuntakul, S.; Kamnardsiri, T.; Lord, S.R.; Maiarin, S.; Worakul, P.; Sungkarat, S. Gait variability during abrupt slow and fast speed transitions in older adults with mild cognitive impairment. PLoS ONE 2022, 17, e0276658. [Google Scholar] [CrossRef]
- Genon, S.; Eickhoff, S.B.; Kharabian, S. Linking interindividual variability in brain structure to behaviour. Nat. Rev. Neurosci. 2022, 23, 307–318. [Google Scholar] [CrossRef]
- Saha, S.; Baumert, M. Intra- and Inter-subject Variability in EEG-Based Sensorimotor Brain Computer Interface: A Review. Front. Comput. Neurosci. 2019, 13, 87. [Google Scholar] [CrossRef]
- Crawford, L.; Mills, E.; Meylakh, N.; Macey, P.M.; Macefield, V.G.; Henderson, L.A. Brain activity changes associated with pain perception variability. Cereb. Cortex 2022, 33, 4145–4155. [Google Scholar] [CrossRef]
- Siepmann, M.; Weidner, K.; Petrowski, K.; Siepmann, T. Heart Rate Variability: A Measure of Cardiovascular Health and Possible Therapeutic Target in Dysautonomic Mental and Neurological Disorders. Appl. Psychophysiol. Biofeedback 2022, 47, 273–287. [Google Scholar] [CrossRef]
- Laborde, S.; Allen, M.S.; Borges, U.; Dosseville, F.; Hosang, T.J.; Iskra, M.; Mosley, E.; Salvotti, C.; Spolverato, L.; Zammit, N.; et al. Effects of voluntary slow breathing on heart rate and heart rate variability: A systematic review and a meta-analysis. Neurosci. Biobehav. Rev. 2022, 138, 104711. [Google Scholar] [CrossRef]
- Arantes, F.S.; Rosa Oliveira, V.; Leao, A.K.M.; Afonso, J.P.R.; Fonseca, A.L.; Fonseca, D.R.P.; Mello, D.; Costa, I.P.; Oliveira, L.V.F.; da Palma, R.K. Heart rate variability: A biomarker of frailty in older adults? Front Med. 2022, 9, 1008970. [Google Scholar] [CrossRef]
- Castiglioni, P.; Merati, G. Fractal analysis of heart rate variability reveals alterations of the integrative autonomic control of circulation in paraplegic individuals. Physiol. Meas. 2017, 38, 774–786. [Google Scholar] [CrossRef]
- Aguillard, D.; Zarubin, V.; Wilson, C.; Steinmetz, K.R.M.; Martsberger, C. Investigating fractal dimension, heart rate variability, and memory during different image sequencing regimes in young adults. Chaos 2020, 30, 113116. [Google Scholar] [CrossRef]
- Bobba-Alves, N.; Juster, R.-P.; Picard, M. The energetic cost of allostasis and allostatic load. Psychoneuroendocrinology 2022, 146, 105951. [Google Scholar] [CrossRef] [PubMed]
- Smith, S.M.; Vale, W.W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci. 2006, 8, 383–395. [Google Scholar] [CrossRef]
- Perrin, A.J.; Horowitz, M.A.; Roelofs, J.; Zunszain, P.A.; Pariante, C.M. Glucocorticoid Resistance: Is It a Requisite for Increased Cytokine Production in Depression? A Systematic Review and Meta-Analysis. Front. Psychiatry 2019, 10, 423. [Google Scholar] [CrossRef]
- Wingfield, J.C. The Concept of Allostasis: Coping with a Capricious Environment. J. Mammal. 2005, 86, 248–254. [Google Scholar] [CrossRef]
- Wingfield, J.C.; Pérez, J.H.; Krause, J.S.; Word, K.R.; González-Gómez, P.L.; Lisovski, S.; Chmura, H.E. How birds cope physiologically and behaviourally with extreme climatic events. Philos. Trans. R. Soc. B Biol. Sci. 2017, 372, 20160140. [Google Scholar] [CrossRef] [PubMed]
- Lavorgna, L.; Moccia, M.; Russo, A.; Palladino, R.; Riccio, L.; Lanzillo, R.; Morra, V.B.; Tedeschi, G.; Bonavita, S. Health-care disparities stemming from sexual orientation of Italian patients with Multiple Sclerosis: A cross-sectional web-based study. Mult. Scler. Relat. Disord. 2017, 13, 28–32. [Google Scholar] [PubMed]
- McEwen, B.S.; Wingfield, J.C. What is in a name? Integrating homeostasis, allostasis and stress. Horm. Behav. 2010, 57, 105–111. [Google Scholar] [CrossRef]
- Romero, L.M.; Wingfield, J.C.; Romero, L.M.; Wingfield, J.C. 69Models of Stress. In Tempests, Poxes, Predators, and People: Stress in Wild Animals and How They Cope; Oxford University Press: Oxford, UK, 2015. [Google Scholar]
- Arnaldo, I.; Corcoran, A.W.; Friston, K.J.; Ramstead, M.J.D. Stress and its sequelae: An active inference account of the etiological pathway from allostatic overload to depression. Neurosci. Biobehav. Rev. 2022, 135, 104590. [Google Scholar] [CrossRef]
- Stephan, Y.; Sutin, A.R.; Luchetti, M.; Terracciano, A. Allostatic Load and Personality: A 4-Year Longitudinal Study. Psychosom. Med. 2016, 78, 302–310. [Google Scholar] [CrossRef]
- Johns, D.W.; Marchant, T.A.; Fairhurst, G.D.; Speakman, J.R.; Clark, R.G. Biomarker of burden: Feather corticosterone reflects energetic expenditure and allostatic overload in captive waterfowl. Funct. Ecol. 2018, 32, 345–357. [Google Scholar] [CrossRef]
- Sigawi, T.; Lehmann, H.; Hurvitz, N.; Ilan, Y. Constrained disorder principle-based second-generation algorithms implement quantified variability signatures to improve the function of complex systems. J. Bioinform. Syst. Biol. 2023, 6, 82–89. [Google Scholar] [CrossRef]
- Innes, A.D.; Campion, P.D.; Griffiths, F.E. Complex consultations and the ‘edge of chaos’. Br. J. Gen. Pract. J. R. Coll. Gen. Pract. 2005, 55, 47–52. [Google Scholar]
- Schneider, P.; Schneider, G. De Novo Design at the Edge of Chaos. J. Med. Chem. 2016, 59, 4077–4086. [Google Scholar] [CrossRef]
- Prior, L. Allostatic Load and Exposure Histories of Disadvantage. Int. J. Environ. Res. Public Health 2021, 18, 7222. [Google Scholar] [CrossRef]
- Korte, S.M.; Koolhaas, J.M.; Wingfield, J.C.; McEwen, B.S. The Darwinian concept of stress: Benefits of allostasis and costs of allostatic load and the trade-offs in health and disease. Neurosci. Biobehav. Rev. 2005, 29, 3–38. [Google Scholar] [CrossRef] [PubMed]
- Lupien, S.J.; McEwen, B.S.; Gunnar, M.R.; Heim, C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. Neurosci. 2009, 10, 434–445. [Google Scholar] [CrossRef] [PubMed]
- McEwen, B.S. Stress, Adaptation, and Disease: Allostasis and Allostatic Load. Ann. N. Y. Acad. Sci. 1998, 840, 33–44. [Google Scholar] [CrossRef]
- McEwen, B.S. Allostasis, Allostatic Load, and the Aging Nervous System: Role of Excitatory Amino Acids and Excitotoxicity. Neurochem. Res. 2000, 25, 1219–1231. [Google Scholar] [CrossRef] [PubMed]
- Guidi, J.; Lucente, M.; Sonino, N.; Fava, G.A. Allostatic Load and Its Impact on Health: A Systematic Review. Psychother. Psychosom. 2021, 90, 11–27. [Google Scholar] [CrossRef]
- Gostoli, S.; Bonomo, M.; Roncuzzi, R.; Biffi, M.; Boriani, G.; Rafanelli, C. Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD). Int. J. Cardiol. 2016, 220, 360–364. [Google Scholar] [CrossRef]
- Guidi, J.; Offidani, E.; Rafanelli, C.; Roncuzzi, R.; Sonino, N.; Fava, G.A. The Assessment of Allostatic Overload in Patients with Congestive Heart Failure by Clinimetric Criteria. Stress Health 2016, 32, 63–69. [Google Scholar] [CrossRef]
- Guidi, J.; Lucente, M.; Piolanti, A.; Roncuzzi, R.; Rafanelli, C.; Sonino, N. Allostatic overload in patients with essential hypertension. Psychoneuroendocrinology 2020, 113, 104545. [Google Scholar] [CrossRef]
- Parker, H.W.; Abreu, A.M.; Sullivan, M.C.; Vadiveloo, M.K. Allostatic Load and Mortality: A Systematic Review and Meta-Analysis. Am. J. Prev. Med. 2022, 63, 131–140. [Google Scholar] [CrossRef]
- Bosch, T.C.; Adamska, M.; Augustin, R.; Domazet-Loso, T.; Foret, S.; Fraune, S.; Funayama, N.; Grasis, J.; Hamada, M.; Hatta, M.; et al. How do environmental factors influence life cycles and development? An experimental framework for early-diverging metazoans. Bioessays 2014, 36, 1185–1194. [Google Scholar] [CrossRef] [PubMed]
- Bernhardt, J.R.; O’Connor, M.I.; Sunday, J.M.; Gonzalez, A. Life in fluctuating environments. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2020, 375, 20190454. [Google Scholar] [CrossRef]
- McEwen, B.S.; Gianaros, P.J. Stress- and allostasis-induced brain plasticity. Annu. Rev. Med. 2011, 62, 431–445. [Google Scholar] [CrossRef] [PubMed]
- Schneiderman, N.; Ironson, G.; Siegel, S.D. Stress and health: Psychological, behavioral, and biological determinants. Annu. Rev. Clin. Psychol. 2005, 1, 607–628. [Google Scholar] [CrossRef]
- Wingfield, J.C.; Krause, J.S.; Perez, J.H.; Chmura, H.E.; Németh, Z.; Word, K.R.; Calisi, R.M.; Meddle, S.L. A mechanistic approach to understanding range shifts in a changing world: What makes a pioneer? Gen. Comp. Endocrinol. 2015, 222, 44–53. [Google Scholar] [CrossRef]
- Snell-Rood, E.; Snell-Rood, C. The developmental support hypothesis: Adaptive plasticity in neural development in response to cues of social support. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 2020, 375, 20190491. [Google Scholar] [CrossRef]
- Lipowska, M.M.; Sadowska, E.T.; Palme, R.; Koteja, P. Evolution of an increased performance under acute challenge does not exacerbate vulnerability to chronic stress. Sci. Rep. 2022, 12, 2126. [Google Scholar] [CrossRef]
- Logan, J.; Barksdale, D. Allostasis and allostatic load: Expanding the discourse on stress and cardiovascular disease. J. Clin. Nurs. 2008, 17, 201–208. [Google Scholar] [CrossRef]
- Ganzel, B.L.; Morris, P.A.; Wethington, E. Allostasis and the human brain: Integrating models of stress from the social and life sciences. Psychol. Rev. 2010, 117, 134–174. [Google Scholar] [CrossRef]
- Korzan, W.J.; Summers, C.H. Evolution of stress responses refine mechanisms of social rank. Neurobiol. Stress 2021, 14, 100328. [Google Scholar] [CrossRef]
- Weaver, I.C.G.; Cervoni, N.; Champagne, F.A.; D’Alessio, A.C.; Sharma, S.; Seckl, J.R.; Dymov, S.; Szyf, M.; Meaney, M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7, 847–854. [Google Scholar] [CrossRef] [PubMed]
- Eling, N.; Morgan, M.D.; Marioni, J.C. Challenges in measuring and understanding biological noise. Nat. Rev. Genet. 2019, 20, 536–548. [Google Scholar] [CrossRef] [PubMed]
- Harton, M.D.; Batchelor, E. Determining the Limitations and Benefits of Noise in Gene Regulation and Signal Transduction through Single Cell, Microscopy-Based Analysis. J. Mol. Biol. 2017, 429, 1143–1154. [Google Scholar] [CrossRef] [PubMed]
- McEwen, C.A. Connecting the biology of stress, allostatic load and epigenetics to social structures and processes. Neurobiol. Stress 2022, 17, 100426. [Google Scholar] [CrossRef]
- Moss, F.; Ward, L.M.; Sannita, W.G. Stochastic resonance and sensory information processing: A tutorial and review of application. Clin. Neurophysiol. 2004, 115, 267–281. [Google Scholar] [CrossRef]
- Meichenbaum, D. Principles and Practice of Stress Management, 3rd ed.; Guilford Press: New York, NY, USA, 2005. [Google Scholar]
- Pascoe, M.C.; Thompson, D.R.; Ski, C.F. Yoga, mindfulness-based stress reduction and stress-related physiological measures: A meta-analysis. Psychoneuroendocrinology 2017, 86, 152–168. [Google Scholar] [CrossRef]
- Ilan, Y. Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects. Mol. Ther. Methods Clin. Dev. 2020, 18, 335–344. [Google Scholar] [CrossRef]
- Kessler, A.; Weksler-Zangen, S.; Ilan, Y. Role of the Immune System and the Circadian Rhythm in the Pathogenesis of Chronic Pancreatitis: Establishing a Personalized Signature for Improving the Effect of Immunotherapies for Chronic Pancreatitis. Pancreas 2020, 49, 1024–1032. [Google Scholar] [CrossRef]
- Ishay, Y.; Kolben, Y.; Kessler, A.; Ilan, Y. Role of circadian rhythm and autonomic nervous system in liver function: A hypothetical basis for improving the management of hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 2021, 321, G400–G412. [Google Scholar] [CrossRef]
- Kolben, Y.; Weksler-Zangen, S.; Ilan, Y. Adropin as a potential mediator of the metabolic system-autonomic nervous system-chronobiology axis: Implementing a personalized signature-based platform for chronotherapy. Obes. Rev. 2021, 22, e13108. [Google Scholar] [CrossRef]
- Kenig, A.; Kolben, Y.; Asleh, R.; Amir, O.; Ilan, Y. Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm. Front. Cardiovasc. Med. 2021, 8, 695547. [Google Scholar] [CrossRef]
- Azmanov, H.; Ross, E.L.; Ilan, Y. Establishment of an Individualized Chronotherapy, Autonomic Nervous System, and Variability-Based Dynamic Platform for Overcoming the Loss of Response to Analgesics. Pain Physician 2021, 24, 243–252. [Google Scholar]
- Potruch, A.; Khoury, S.T.; Ilan, Y. The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs. Seizure 2020, 80, 201–211. [Google Scholar] [CrossRef] [PubMed]
- Isahy, Y.; Ilan, Y. Improving the long-term response to antidepressants by establishing an individualized platform based on variability and chronotherapy. Int. J. Clin. Pharmacol. Ther. 2021, 59, 768–774. [Google Scholar] [CrossRef]
- Khoury, T.; Ilan, Y. Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies. Front. Immunol. 2019, 10, 2726. [Google Scholar] [CrossRef]
- Khoury, T.; Ilan, Y. Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity. Obes. Res. Clin. Pract. 2021, 15, 114–123. [Google Scholar] [CrossRef] [PubMed]
- Kenig, A.; Ilan, Y. A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment. Front. Physiol. 2019, 10, 1542. [Google Scholar] [CrossRef] [PubMed]
- Ilan, Y. Why targeting the microbiome is not so successful: Can randomness overcome the adaptation that occurs following gut manipulation? Clin. Exp. Gastroenterol. 2019, 12, 209–217. [Google Scholar] [CrossRef]
- Gelman, R.; Bayatra, A.; Kessler, A.; Schwartz, A.; Ilan, Y. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: An algorithm-based method for overcoming resistance to antiviral agents. Emerg. Microbes Infect. 2020, 9, 1397–1406. [Google Scholar] [CrossRef]
- Ishay, Y.; Potruch, A.; Schwartz, A.; Berg, M.; Jamil, K.; Agus, S.; Ilan, Y. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomed. Pharmacother. 2021, 143, 112228. [Google Scholar] [CrossRef]
- Ilan, Y.; Spigelman, Z. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance. Cancer Treat. Res. Commun. 2020, 25, 100240. [Google Scholar] [CrossRef] [PubMed]
- Hurvitz, N.; Azmanov, H.; Kesler, A.; Ilan, Y. Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. Eur. J. Hum. Genet. 2021, 29, 1485–1490. [Google Scholar] [CrossRef] [PubMed]
- Ilan, Y. Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response. Front. Med. 2021, 8, 788777. [Google Scholar] [CrossRef]
- Gelman, R.; Berg, M.; Ilan, Y. A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review. Int. J. Environ. Res. Public Health 2022, 19, 1722. [Google Scholar] [CrossRef]
- Azmanov, H.; Bayatra, A.; Ilan, Y. Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects. J. Pain Res. 2022, 15, 1051–1060. [Google Scholar] [CrossRef]
- Hurvitz, N.; Elkhateeb, N.; Sigawi, T.; Rinsky-Halivni, L.; Ilan, Y. Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms. Front. Aging 2022, 3, 1044038. [Google Scholar] [CrossRef]
- Kolben, Y.; Azmanov, H.; Gelman, R.; Dror, D.; Ilan, Y. Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections. Ann. Med. 2023, 55, 311–318. [Google Scholar] [CrossRef]
- Azmanov, H.; Keidar-Haran, T.; Kenig, A.; Kessler, A.; Kolben, Y.; Weksler-Zangen, S.; Ilan, Y. Colchicine at a Low Dose Reduces Liver Inflammation in a Model of Immune-Mediated Hepatitis. Arch. Clin. Biomed. Res. 2023, 7, 215–223. [Google Scholar]
- Lehmann, H.; Arkadir, D.; Ilan, Y. Methods for Improving Brain-Computer Interface: Using A Brain-Directed Adjuvant and A Second-Generation Artificial Intelligence System to Enhance Information Streaming and Effectiveness of Stimuli. Int. J. Appl. Biol. Pharm. Technol. 2023, 14, 42–52. [Google Scholar]
- Adar, O.; Hollander, A.; Ilan, Y. The Constrained Disorder Principle Accounts for the Variability That Characterizes Breathing: A Method for Treating Chronic Respiratory Diseases and Improving Mechanical Ventilation. Adv. Respir. Med. 2023, 91, 350–367. [Google Scholar] [CrossRef]
- Ilan, Y. The Constrained Disorder Principle Accounts for The Structure and Function of Water as An Ultimate Biosensor and Bioreactor in Biological Systems. Int. J. Appl. Biol. Pharm. Technol. 2023, 14, 31–41. [Google Scholar]
- Sigawi, T.; Hamtzany, O.; Shakargy, J.D.; Ilan, Y. The Constrained Disorder Principle May Account for Consciousness. Brain Sci. 2024, 14, 209. [Google Scholar] [CrossRef]
- Ilan, Y. Special Issue “Computer-Aided Drug Discovery and Treatment”. Int. J. Mol. Sci. 2024, 25, 2683. [Google Scholar] [CrossRef]
- Hurvitz, N.; Dinur, T.; Revel-Vilk, S.; Agus, S.; Berg, M.; Zimran, A.; Ilan, Y. A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy. J. Clin. Med. 2024, 13, 3325. [Google Scholar] [CrossRef]
- Ilan, Y. Free Will as Defined by the Constrained Disorder Principle: A Restricted, Mandatory, Personalized, Regulated Process for Decision-Making. Integr. Psychol. Behav. Sci. 2024, 58, 1843–1875. [Google Scholar] [CrossRef]
- Ilan, Y. The Constrained Disorder Principle Defines Mitochondrial Variability and Provides A Platform for A Novel Mechanism for Improved Functionality of Complex Systems. Fortune J. Health Sci. 2024, 7, 338–347. [Google Scholar]
- Sigawi, T.; Israeli, A.; Ilan, Y. Harnessing Variability Signatures and Biological Noise May Enhance Immunotherapies’ Efficacy and Act as Novel Biomarkers for Diagnosing and Monitoring Immune-Associated Disorders. Immunotargets Ther. 2024, 13, 525–539. [Google Scholar] [CrossRef] [PubMed]
- Ilan, Y. Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes. Front. Digit. Health 2020, 2, 569178. [Google Scholar] [CrossRef]
- Ilan, Y. Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor. Int. J. Environ. Res. Public Health 2021, 18, 811. [Google Scholar] [CrossRef]
- Ilan, Y. Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases. J. Pers. Med. 2022, 12, 1303. [Google Scholar] [CrossRef]
- Gelman, R.; Hurvitz, N.; Nesserat, R.; Kolben, Y.; Nachman, D.; Jamil, K.; Agus, S.; Asleh, R.; Amir, O.; Berg, M.; et al. A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial. Biomed. Pharmacother. 2023, 161, 114334. [Google Scholar] [CrossRef]
- Russo, M.A.; Santarelli, D.M.; O’Rourke, D. The physiological effects of slow breathing in the healthy human. Breathe 2017, 13, 298–309. [Google Scholar] [CrossRef] [PubMed]
- Parati, G.; Stergiou, G.S.; Dolan, E.; Bilo, G. Blood pressure variability: Clinical relevance and application. J. Clin. Hypertens. 2018, 20, 1133–1137. [Google Scholar] [CrossRef]
- Mehlum, M.H.; Liestøl, K.; Kjeldsen, S.E.; Julius, S.; Hua, T.A.; Rothwell, P.M.; Mancia, G.; Parati, G.; Weber, M.A.; Berge, E. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. Eur. Heart J. 2018, 39, 2243–2251. [Google Scholar] [CrossRef] [PubMed]
- Beevers, G.; Lip, G.Y.H.; O’Brien, E. The pathophysiology of hypertension. BMJ 2001, 322, 912–916. [Google Scholar] [CrossRef] [PubMed]
- Mocayar Marón, F.J.; Ferder, L.; Saraví, F.D.; Manucha, W. Hypertension linked to allostatic load: From psychosocial stress to inflammation and mitochondrial dysfunction. Stress 2019, 22, 169–181. [Google Scholar] [CrossRef]
- James, G.D. The Adaptive Value and Clinical Significance of Allostatic Blood Pressure Variation. Curr. Hypertens. Rev. 2019, 15, 93–104. [Google Scholar] [CrossRef]
- Oparil, S.; Schmieder, R.E. New approaches in the treatment of hypertension. Circ. Res. 2015, 116, 1074–1095. [Google Scholar]
- McCrory, C.; McLoughlin, S.; Layte, R.; NiCheallaigh, C.; O’Halloran, A.M.; Barros, H.; Berkman, L.F.; Bochud, M.; Crimmins, E.M.; Farrell, M.T.; et al. Towards a consensus definition of allostatic load: A multi-cohort, multi-system, multi-biomarker individual participant data (IPD) meta-analysis. Psychoneuroendocrinology 2023, 153, 106117. [Google Scholar] [CrossRef]
- Hurvitz, N.; Ilan, Y. The Constrained-Disorder Principle Assists in Overcoming Significant Challenges in Digital Health: Moving from “Nice to Have” to Mandatory Systems. Clin. Pract. 2023, 13, 994–1014. [Google Scholar] [CrossRef]
- Sigawi, T.; Ilan, Y. Using Constrained-Disorder Principle-Based Systems to Improve the Performance of Digital Twins in Biological Systems. Biomimetic 2023, 8, 359. [Google Scholar] [CrossRef]
- Bayatra, A.; Nasserat, R.; Ilan, Y. Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness Using a Personalized Second-generation Digital System. Curr. Pharm. Biotechnol. 2024, 25, 2078–2088. [Google Scholar] [CrossRef]
- Ilan, Y. The constrained-disorder principle defines the functions of systems in nature. Front. Netw. Physiol. 2024, 4, 1361915. [Google Scholar] [CrossRef]
- Ilan, Y. Using the Constrained Disorder Principle to Navigate Uncertainties in Biology and Medicine: Refining Fuzzy Algorithms. Biology 2024, 13, 830. [Google Scholar] [CrossRef] [PubMed]
- Ilan, Y. The Constrained Disorder Principle Overcomes the Challenges of Methods for Assessing Uncertainty in Biological Systems. J. Pers. Med. 2025, 15, 10. [Google Scholar]
- Sigawi, T.; Gelman, R.; Maimon, O.; Yossef, A.; Hemed, N.; Agus, S.; Berg, M.; Ilan, Y.; Popovtzer, A. Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: A proof-of-concept open-labeled clinical trial. Front. Oncol. 2024, 14, 1426426. [Google Scholar] [CrossRef]
- Pleasants, N. Free Will, Determinism and the “Problem” of Structure and Agency in the Social Sciences. Philos. Soc. Sci. 2019, 49, 3–30. [Google Scholar] [CrossRef]
CDP | Allostasis | |
---|---|---|
Noise | Noise is inherent to all systems, and its dynamic borders determine their adaptability. | Allostasis accounts for noise. Systems reach a set point for omitting the noise in the surroundings. |
Adaptability | Biological systems adapt to perturbations by changing the range of the internal noise. | Adaptability is based on changing set points in response to perturbations. |
Equilibrium | Systems function at the “edge of chaos” and always manifest a certain degree of noise, which is mandatory for proper functioning. | Systems reach new equilibrium positions by mechanisms involving multiple hormones and cytokines in response to environmental stress. |
Planning ahead of time | Under the CDP, there is no high-level regulation or long-term planning. Existence and efficiency are inherent to systems. | Central control in the brain is associated with planning for a stressful situation and directing the response. |
Energy expenditure | Regulating the degree of noise in a system is a method nature uses to cope with perturbations while saving energy. The CDP focuses on saving energy by regulating noise in the system, omitting resistance to changes, or using forces to change set points. | As the body transforms from allostasis to allostatic load, energy costs associated with allostasis and stress compete with growth, maintenance, and repair. Glucocorticoids play a role in energy balance, determining responses to energetic demands (allostatic load) and influencing subsequent physiology and behavior associated with coping. |
Reaching stability | The body adapts to changes in its internal and external environments to maintain stable function, even if this means continuous instability. | The body can adapt to changes in its internal and external environment to maintain a stable physiological state. |
Scope of influence | All body functions, from the DNA to whole organ levels, are subject to the process of regulating noise. | Depending on the reaction, hormone levels, heart rate, blood pressure, and immune function change. |
Regulatory mechanisms | Regulation occurs at the cell, tissue, or organ levels in parallel to central regulation by the brain. | The brain regulates allostasis by constantly monitoring the body’s internal and external environment and adjusting physiological responses accordingly. |
Disease states | Chronic or repeated exposure to stressors does not disrupt function, which is met by changes in noise ranges by the variable dynamic boundaries. Disease states are associated with boundary malfunctions and too much or too little noise in the system. | Chronic or repeated exposure to stressors disrupts the allostatic process, negatively impacting health. |
Balance | The CDP does not aim to reach a balance; living at the edge of chaos is essential for proper function. | Balancing stress and rest is crucial for optimal health and well-being. |
Differentiation of functional systems | The CDP does not distinguish between systems; all body systems are mandatory for function and react to perturbations. | Allostasis distinguishes between critical systems for life (“homeostasis”) and systems that maintain balance (“allostasis”) in response to environmental and life stage changes. |
Equilibrium set points | The CDP implies that biology is dynamic, with no specific “final set point” for which the body aims. Systems function at the edge of chaos. | Allostasis contends that biology is dynamic, and set points rarely remain constant, contrary to reactive, thermostat-like homeostasis models. A new set point is the new equilibrium state. |
Predicting adverse health outcomes | Variability is a measure of system functioning. It enables early disease detection, prognosis evaluation, and monitoring of therapeutic responses. Assessing a system’s variability level can yield early prediction indicators. | The allostatic load model proposes that measuring multi-systemic interactions among primary mediators and effects, along with sub-clinically relevant biomarkers representing secondary outcomes, can enhance the prediction of pathologies, aiding in the prevention of stress-related diseases. |
Plasticity | Changes in variability boundaries represent the system’s plasticity and ability to adapt to changes. | Plasticity can occur within or across generations, allowing organisms to optimize their responses to general and cue-specific environmental perturbations. |
Impacts of biological noise | Widening or tightening variability borders in low or high biological noise systems may improve medication response by overcoming drug tolerance. | Controlled exposure to biological noise may enhance a patient’s ability to cope with various stressors, induce allostasis, and improve overall health outcomes. |
Adding noise to improve outcome | Noise is inherent to all systems at all levels. The widening or tightening of its boundaries serves as an adaptation mechanism to regulate the amount of noise in a system to improve its function. If the noise is too high, it implies a need for its constraints; if it is too low, widening the boundaries enables it to increase. The goal of regulating noise is not to reach a new set point but to improve functioning at the edge of chaos in an energy-conserving way. | Adding noise may require systems to spend energy to reach a new set point and equilibrium state. |
Timeframe | Highlights the dynamic nature of noise and adaptation in real time without considering specific timeframes | It encompasses acute responses to immediate stress challenges and chronic adaptations over extended periods. |
Impact of chronic stress | Chronic stress is accommodated by adjusting noise ranges within dynamic boundaries. | Chronic stress disrupts allostasis processes, leading to maladaptive changes and allostatic load and overload. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Adar, O.; Shakargy, J.D.; Ilan, Y. The Constrained Disorder Principle: Beyond Biological Allostasis. Biology 2025, 14, 339. https://doi.org/10.3390/biology14040339
Adar O, Shakargy JD, Ilan Y. The Constrained Disorder Principle: Beyond Biological Allostasis. Biology. 2025; 14(4):339. https://doi.org/10.3390/biology14040339
Chicago/Turabian StyleAdar, Ofek, Josef Daniel Shakargy, and Yaron Ilan. 2025. "The Constrained Disorder Principle: Beyond Biological Allostasis" Biology 14, no. 4: 339. https://doi.org/10.3390/biology14040339
APA StyleAdar, O., Shakargy, J. D., & Ilan, Y. (2025). The Constrained Disorder Principle: Beyond Biological Allostasis. Biology, 14(4), 339. https://doi.org/10.3390/biology14040339